Science Explorer Interactive view Map
Research facility · Vienna · Austria

Institute for Pharmaeconomic Research

ipf-ac.atROR OpenAlex
World rank, all time
#37,244
of 42,892
Rank in Austria
#254
of 287
Research works
188
▼ 3% vs 2013–17
Citations
1.3k
7.1 per fractional work
Top-10% rate
6.7%
record average 16.5%
Open access
23%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.70× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.19× its world share, 1 worksImmunology and Micro…Neuroscience: 1.32× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.68× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.30× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringMathematics: 0.34× its world share, 0 worksMathematicsHealth Professions: 2.89× its world share, 2 worksHealth ProfessionsMedicine: 2.27× its world share, 10 worksMedicineNursing: 3.64× its world share, 0 worksNursingArts and Humanities: 0.49× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 11.71× its world share, 6 worksEconomics, Econometr…Psychology: 0.31× its world share, 0 worksPsychologySocial Sciences: 0.51× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 11.7×. Every wedge is a field page.

Who are the top researchers at Institute for Pharmaeconomic Research?

Ranked on the composite score, E. Walter lead among researchers whose main affiliation is Institute for Pharmaeconomic Research.

  1. 1 E. Walter Austria · #591,145 worldwide 73 citations · 35 works
All ranked researchers at Institute for Pharmaeconomic Research

Which keywords describe research at Institute for Pharmaeconomic Research?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Drug Development Costs, Generic Drugs, COVID-19 Vaccine, Vaccine Hesitancy and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Quality of Life4▲ 12×2 topics
  2. Cost-effectiveness Analysis3▲ 173×1 topic
  3. Health Utility Measures3▲ 173×1 topic
  4. Epidemiology2▲ 2.6×14 topics
  5. Inflammation2▲ 3.6×5 topics
  6. Drug Development Costs2▲ 260×1 topic
  7. Generic Drugs2▲ 260×1 topic
  8. Public Health2▲ 4.8×6 topics
  9. COVID-19 Vaccine2▲ 89×1 topic
  10. Vaccine Hesitancy2▲ 96×1 topic
  11. Prevention1▲ 14×5 topics
  12. Cognitive Dysfunction1▲ 97×2 topics
  13. Treatment1▲ 4.5×2 topics
  14. Delirium1▲ 80×1 topic
  15. Intensive Care Unit1▲ 35×1 topic

Which research topics does Institute for Pharmaeconomic Research publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Vaccine Coverage and Hesitancy and Intensive Care Unit Cognitive Disorders.

Health Systems, Economic…3Health Systems, Economic Evaluations, Quality of Life: 3 fractional worksPharmaceutical Economics…2Pharmaceutical Economics and Policy: 2 fractional worksVaccine Coverage and Hes…2Vaccine Coverage and Hesitancy: 2 fractional worksIntensive Care Unit Cogn…1Intensive Care Unit Cognitive Disorders: 1 fractional worksWound Healing and Treatm…1Wound Healing and Treatments: 1 fractional worksPressure Ulcer Preventio…1Pressure Ulcer Prevention and Management: 1 fractional worksHealth and Medical Studies: 1 fractional worksRespiratory viral infections research: 1 fractional worksHeart Failure Treatment and Management: 1 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional works
Economics and EconometricsHealthCritical Care and Intensive Care MedicineRehabilitation5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  3. 3 Vaccine Coverage and Hesitancy Health 2 works
  4. 4 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 1 works
  5. 5 Wound Healing and Treatments Rehabilitation 1 works
  6. 6 Pressure Ulcer Prevention and Management Occupational Therapy 1 works
  7. 7 Health and Medical Studies General Health Professions 1 works
  8. 8 Respiratory viral infections research Epidemiology 1 works
  9. 9 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
  10. 10 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.8%not open77.2%

World: 28% of research is openly available.

with international co-authors16.2%domestic only83.8%

World: 19% is written across borders.

How has Institute for Pharmaeconomic Research's research output changed?

Output in 2018–2022 was 3% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.